The VR Foundation Board of Directors today announced the resignation of Igor Korobko, PhD, DSci, who has served as Chief Scientific Director of the organization since it's inception. Dr. Korobko had informed the Board he intended to resign and focus on his academic career at the end of 2016. And he felt that moving up his resignation date to after the AAD Congress in early March of 2017 would allow VRF to complete the ongoing projects and to facilitate VRF’s continuing focus on its broader mission.
While the Board has the utmost regard for Dr. Korobko’s skills, professionalism and integrity, it accepted his resignation. The Board expressed its gratitude to Dr. Korobko for his unparalleled service as the Chief Scientific Director.
Among the many accomplishments of VRF under his scientific leadership was the development, in 2011, of the first comprehensive Vitiligo Electronic Health Record and Vitiligo Biobank Network, the translation of science into clinical interventions and drug repurposing, and regular Quarterly Reports. “We are grateful for Dr. Korobko’s distinguished tenure and numerous contributions,” the Board said. “Our non-profit organization has been very fortunate to have Dr. Korobko as Chief Scientific Director for so many years, and we wish him well.”
Dr. Korobko will continue his academic research as a Deputy Director and Head of the lab at the Institute of Gene Biology in Moscow, Russia. The Board will appoint a successor to the Chief Scientific Director in the near future.
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
VITFriends Fundraising and Awareness Concert in Boston
Featuring: M.C. - Mary-dith Tuitt Jazz vocalist - Katani Summer Steel drum instrumentalist - Justin Petty Vocalist - Emily Orji and Dr. Victor Huan...30 April 2017 14:30, Salvation Army Kroc Center, 650 Du...
Vitiligo Walk-A-Thon in Fort Dallas
The annual Vitiligo Walkathon is organized by Dallas Fort Worth Vitiligo Support Group on May 20, 2017. This is an event held to raise awareness about vitiligo in the...20 May 2017 09:00, Dallas, Texas
Can Scenesse be used for vitiligo treatment?
The drug Scenesse from Clinuvel has been tested in clinical trials in relation vitiligo. Profs. Henry Lim, Mark Lebwohl and coauthors reported (PubMed) results of mult...
How long does it take to treat vitiligo?
Treatment results will vary by person and type of vitiligo. The rule of thumb is that you will need to allow at least 3 to 6 months before you begin to see results fro...
Will it spread?
The condition varies from person to person. Some people only get a few small, white patches that progress no further. Other people get bigger white patches that join u...
What causes vitiligo?
The precise cause of vitiligo is not well understood. The white areas appear due to loss of the pigment (melanin) that gives skin its color and protects it from the su...